This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Effectiveness results
The mean time to emergence (eye opening) and response to command were (SD) 2.2 minutes (+/-1.5) and 3.0 (+/-3.2) minutes, respectively in the BAL group, whereas the corresponding figures in the TIVA group were 8.8 (+/-4.4) and 9.2 (+/-4.5) minutes, and in the INH group 8.5 (+/-4.8) and 8.9 (+/-5.4) minutes, respectively. These two measures of recovery time were statistically significantly shorter in the BAL group that in the other two groups (p<0.0001). In the BAL group, 48% of patients experienced nausea and/or vomiting (although only half of those needed treatment with antiemetic medications) compared with 23% and 16% of patients in the INH and TIVA groups, respectively (p<0.02). Overall patient satisfaction and mean times to discharge from PACU and hospital were rapid and similar in all three groups. Intraoperatively, no patient experienced surgical or anaesthesia-related complications of 'clinical importance'.
Measure of benefits used in the economic analysis
Since no differences were found in overall patient satisfaction or overall recovery time, the economic analysis was based on costs only.
Direct costs
Cost estimates included anaesthetic and postoperativedrugs, and bedside nursing time. Quantities of resource use were not reported separately from the costs. The unit costs were based on the purchasing price of the anaesthetic drugs (as of 1995) and the average salary of middle rank nurses during the study (dates not specified). The costs associated with the expenditures on nitrous oxide and oxygen were excluded. The overall price year was not reported.
Currency
Canadian dollars (Can$).
Sensitivity analysis
No sensitivity analysis was performed.
Estimated benefits used in the economic analysis
Not applicable.
Cost results
The mean total cost per patient (SD) was Can$36.4 (+/-5.3), Can$66.5 (+/-11.7), and Can$86.2 (+/-20.6)for the INH, BAL and TIVA groups (p<0.001), respectively.
Synthesis of costs and benefits
Authors' conclusions
For arthroscopic knee surgery, INH anaesthesia with isoflurane/fentanyl/N2O (INH) is associated with similar hospital discharge times, and comparable levels of patient satisfaction as either BAL or TIVA. The BAL option results in the most rapid time to awakening, but has a higher incidence of postoperative nausea and vomiting. Overall, INH had the lowest anaesthetic costs, and similar nursing and extra in-hospital costs. Therefore, there appears to be a potential pharmacoeconomic benefit associated with theuse of a "standard" isoflurane/fentanyl/N2O anaesthetic for brief outpatient surgery.
CRD COMMENTARY -Selection of comparators
A justification was given for comparator used. The isoflurane/fentanyl/N2O (INH) strategy was reported as the standard inhalational anaesthetic. You, as a user of this database, should consider whether these are widely used technologies in your own setting.
Validity of estimate of measure of benefit
The estimates of effectiveness were based on a small randomised, double-blinded clinical trial. The sample size was determined using power calculation. The internal validity of such a study is generally considered high. The authors noted that different opioids were administered in different relative doses to the threegroups.
Validity of estimate of costs
Quantities of resource use were not reported separately from the costs. However, adequate details of cost estimation were provided. The dates associated with the data collection or prices used were not provided. The cost associated with the expenditures on nitrous oxide and oxygen were omitted. Also, the cost of time spent in different units (operating room, PACU, DCU) was not accounted for.
Other issues
The authors' conclusions are justified given the uncertainties in the data. Some reservations, however, are warranted considering the completeness of the cost estimation. The results obtained from a single hospital may not be generalisable to the other settings, or other countries. No sensitivity analysis was carried out in order to enhance generalisability.
